News | Magnetic Resonance Imaging (MRI) | May 26, 2020

MRI's Environmental Impact

Gadolinium found in elevated amounts near water treatment plants in Tokyo rivers

Researchers from Tokyo Metropolitan University have surveyed the amount of gadolinium found in river water in Tokyo. Gadolinium is contained in contrast agents given to patients undergoing medical magnetic resonance imaging (MRI) scans, and it has been shown in labs to become toxic when exposed to ultraviolet rays. The researchers found significantly elevated levels, particularly near water treatment plants, highlighting the need for new public policy and removal technologies as MRI become even more commonp

Samples were taken along rivers around Tokyo. Measurements of rare earth element quantities indicate a clearly elevated amount of gadolinium compared to that in natural shale. Graphics courtesy of Tokyo Metropolitan University

May 26, 2020 — Researchers from Tokyo Metropolitan University have surveyed the amount of gadolinium found in river water in Tokyo. Gadolinium is contained in contrast agents given to patients undergoing medical magnetic resonance imaging (MRI) scans, and it has been shown in labs to become toxic when exposed to ultraviolet rays. The researchers found significantly elevated levels, particularly near water treatment plants, highlighting the need for new public policy and removal technologies as MRI become even more commonplace.

Modern medicine owes a lot to MRI. Doctors can see tumors, inflammation and hemorrhaging deep inside the human body without the need for invasive surgery; unlike CT scans, patients are also not exposed to any ionizing radiation. Its many benefits have meant that MRI machines are now more wide-spread than ever. For example, in 1995, Japan had 6.12 machines per million residents; in 2017, it had 55.21, the highest number per million in the world.

But it might not be all good news. MRI imaging is often carried out after patients are injected with a contrast agent which makes features inside the body clearer in scans. It contains gadolinium, an originally toxic rare earth element that is rendered safe for medical use by binding it to a chelation agent, making it unreactive. After completing its task, 98% of the compound is expelled from a patient's body within 24 hours in the urine and makes its way through the wastewater system. Common wastewater treatment plants cannot remove it, so it passes directly into the environment, albeit in small quantities. On exposure to UV light, lab experiments have shown that it may transform back into a toxic state. This makes it vital to track how much gadolinium finds its way into the environment.

Thus, a team led by Professor Kazumasa Inoue of Tokyo Metropolitan University set out to measure how much gadolinium was being released into rivers in Tokyo. They took samples from a number of locations along the many major rivers of the city. Correcting for the amounts expected in natural shale, they carried out a broad survey of rare earths using mass spectrometry and found a significant elevation in the amount of gadolinium in the water. Importantly, they noticed large spikes in the amounts depending on proximity to water treatment plants. These findings are in agreement with previous work for samples taken inside a treatment plant on the River Weser, Germany.

It should be remembered that the reason why gadolinium is released in the first place is that a patient's kidneys safely pass it from the body. This means that, for the most part, it is also non-reactive in the environment. But as more MRI machines are installed to cater to an ageing population with more healthcare needs, the research team noted that new public policy and the development of new treatment techniques are vital to mitigating the environmental impact of this well-established, lifesaving medical technology.

For more information: www.tmu.ac.jp/english

Related Content of MRI Gadolinium Safety Concerns

The Debate Over Gadolinium MRI Contrast Toxicity

VIDEO: How Serious is MRI Gadolinium Retention in the Brain and Body? An interview with Max Wintermark, M.D.

VIDEO “Big Concerns Remain for MRI Gadolinium Contrast Safety at RSNA 2017,” An interview with Emanuel Kanal, M.D.

Radiology Has Failed to Properly Assess or Track MRI Gadolinium Contrast Safety

Recent Developments in Contrast Media

FDA Committee Votes to Expand Warning Labels on Gadolinium-Based Contrast Agents

European Medicines Agency Issues Update on Gadolinium Contrast Agents

ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents

FDA: No Harm in MRI Gadolinium Retention in the Brain

VIDEO: MRI Gadolinium Contrast Retention in the Brain

Gadolinium May Remain in Brain After Contrast MRI

Related Content

Scientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide physicians in treating patients with the therapies best suited to their disease.

Getty Images

News | Prostate Cancer | September 24, 2021
September 24, 2021 — Scientists have identified two subtypes of metastatic...
Doctors say they should be making medical decisions with patients, not insurance carriers and outline principles for noninvasive testing
News | Cardiac Imaging | September 23, 2021
September 22, 2021 — Test selection should be a shared decision between patient and physician rather than directed by
An illustration based on simulations by Rice University engineers shows a gadolinium ion (blue) in water (red and white), with inner-sphere water -- the water most affected by the gadolinium -- highlighted. The researchers’ models of gadolinium in water show there’s room for improvement in compounds used as contrast agents in clinical magnetic resonance imaging.

An illustration based on simulations by Rice University engineers shows a gadolinium ion (blue) in water (red and white), with inner-sphere water -- the water most affected by the gadolinium -- highlighted. The researchers’ models of gadolinium in water show there’s room for improvement in compounds used as contrast agents in clinical magnetic resonance imaging. Illustration by Arjun Valiya Parambathu

News | Magnetic Resonance Imaging (MRI) | September 20, 2021
September 20, 2021 — ...
Avoiding contrast dyes for imaging tests not necessary if concerned about iodine allergy, peer-reviewed study concludes #MRI

Getty Images

News | Contrast Media Injectors | September 16, 2021
September 16, 2021 — FDB (First Databank), a leading provider of drug and medical device knowledge that helps healthc
Revised guidelines for lung cancer screening eligibility are perpetuating disparities for racial/ethnic minorities, according to a new study in Radiology.

Getty Images

News | Lung Imaging | September 15, 2021
September 15, 2021 — Revised guidelines for...
To get more flexibility and cost savings from storage, healthcare organizations are increasing their investments in the cloud
Feature | Information Technology | September 15, 2021 | By Kumar Goswami
Healthcare organizations today are storing petabytes of medical imaging data — lab slides,...
Figure 1: MWT Schematic of a typical setup for detecting malignant tissues/tumors.

Figure 1: MWT Schematic of a typical setup for detecting malignant tissues/tumors.

Feature | Radiology Imaging | September 14, 2021 | By Brendon McHugh
As with all imaging technologies, COVID-19 is expected to continue to negatively impact the market.

Courtesy of Grand View Research

Feature | Magnetic Resonance Imaging (MRI) | September 14, 2021 | By Melinda Taschetta-Millane